Process View
Any process that modulates the frequency, rate or extent of attachment of a cell to the extracellular matrix.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of cell matrix adhesion"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.997 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.996 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.989 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.985 | Human | |
| EGFR | epidermal growth factor receptor | 0.964 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.959 | Human | |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.956 | ||
| FHL2 | four and a half LIM domains 2 | 0.943 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.941 | Human | |
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.936 | ||
| NCK2 | NCK adaptor protein 2 | 0.922 | ||
| S100A8 | S100 calcium binding protein A8 | 0.920 | Human | |
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.918 | Human | |
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.866 | Rat | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.858 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.854 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.853 | ||
| FN1 | fibronectin 1 | 0.810 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.797 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.762 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.759 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.755 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.737 | ||
| NRP1 | neuropilin 1 | 0.712 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.682 | ||
| PLAU | plasminogen activator, urokinase | 0.660 | ||
| HOXB5 | homeobox B5 | 0.654 | Human | |
| ENG | endoglin | 0.631 | ||
| S100A6 | S100 calcium binding protein A6 | 0.582 | Human | |
| S100A9 | S100 calcium binding protein A9 | 0.581 | Human | |
| DLG1 | discs, large homolog 1 (Drosophila) | 0.570 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.550 | Human | |
| EPHA2 | EPH receptor A2 | 0.549 | Human | |
| SMAD7 | SMAD family member 7 | 0.548 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.514 | ||
| S100A4 | S100 calcium binding protein A4 | 0.509 | Human | |
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.471 | ||
| MPDZ | multiple PDZ domain protein | 0.437 | ||
| ANGPT2 | angiopoietin 2 | 0.417 | ||
| EFNA1 | ephrin-A1 | 0.410 | Human | |
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.394 | ||
| ABI2 | abl-interactor 2 | 0.392 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.376 | ||
| HOXA5 | homeobox A5 | 0.375 | Human | |
| BMP2 | bone morphogenetic protein 2 | 0.375 | ||
| AREG | amphiregulin | 0.369 | ||
| CCND1 | cyclin D1 | 0.358 | ||
| SFN | stratifin | 0.351 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.349 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.336 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.327 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.322 | ||
| SMAD2 | SMAD family member 2 | 0.322 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.317 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.301 | ||
| EPHA7 | EPH receptor A7 | 0.285 | Human | |
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.279 | Human | |
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.266 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.266 | ||
| ANXA2 | annexin A2 | 0.254 | ||
| JUP | junction plakoglobin | 0.252 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.241 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.233 | ||
| APC | adenomatous polyposis coli | 0.233 | ||
| S100A11 | S100 calcium binding protein A11 | 0.217 | Human | |
| PXN | paxillin | 0.209 | Human | |
| PDGFC | platelet derived growth factor C | 0.208 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.208 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.207 | Human | |
| HOXB7 | homeobox B7 | 0.204 | Human | |
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.203 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.198 | Mouse | |
| BCL2L1 | BCL2-like 1 | 0.196 | ||
| ZNF746 | zinc finger protein 746 | 0.193 | ||
| GBP3 | guanylate binding protein 3 | 0.185 | ||
| TSC2 | tuberous sclerosis 2 | 0.175 | ||
| S100B | S100 calcium binding protein B | 0.172 | Human | |
| F11R | F11 receptor | 0.168 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.162 | Human | |
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.161 | ||
| HOXB6 | homeobox B6 | 0.150 | Human | |
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.150 | ||
| PLAT | plasminogen activator, tissue | 0.147 | Human | |
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.139 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.138 | ||
| AXIN1 | axin 1 | 0.135 | ||
| LPXN | leupaxin | 0.135 | Human | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.134 | ||
| HOXA10 | homeobox A10 | 0.134 | ||
| HOXB3 | homeobox B3 | 0.132 | ||
| GDF5 | growth differentiation factor 5 | 0.123 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.119 | ||
| DTNA | dystrobrevin, alpha | 0.115 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.114 | ||
| HOXA1 | homeobox A1 | 0.113 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.111 | ||
| TNC | tenascin C | 0.108 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.108 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.105 | Human | |
| DSG2 | desmoglein 2 | 0.105 | ||
| ANGPT1 | angiopoietin 1 | 0.102 | ||
| PGF | placental growth factor | 0.102 | Human | |
| MAP3K11 | mitogen-activated protein kinase kinase kinase 11 | 0.101 | ||
| HOXA7 | homeobox A7 | 0.099 | ||
| BTRC | beta-transducin repeat containing | 0.099 | ||
| ZYX | zyxin | 0.096 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.096 | ||
| DOCK1 | dedicator of cytokinesis 1 | 0.095 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.091 | ||
| DST | dystonin | 0.090 | ||
| YAP1 | Yes-associated protein 1 | 0.089 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.086 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.086 | ||
| PTRF | polymerase I and transcript release factor | 0.085 | ||
| INHBA | inhibin, beta A | 0.085 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.084 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.083 | ||
| PRKD2 | protein kinase D2 | 0.083 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.082 | ||
| PCDH9 | protocadherin 9 | 0.081 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.081 | ||
| S100A1 | S100 calcium binding protein A1 | 0.081 | Human | |
| TGFB3 | transforming growth factor, beta 3 | 0.080 | ||
| WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | 0.079 | ||
| EFNB2 | ephrin-B2 | 0.078 | Human | |
| HOXA4 | homeobox A4 | 0.076 | Human | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.075 | ||
| RANBP9 | RAN binding protein 9 | 0.075 | ||
| BMP4 | bone morphogenetic protein 4 | 0.074 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.074 | ||
| KITLG | KIT ligand | 0.073 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.073 | ||
| LMNA | lamin A/C | 0.072 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.071 | ||
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.070 | ||
| DEAF1 | deformed epidermal autoregulatory factor 1 (Drosophila) | 0.070 | ||
| SNX33 | sorting nexin 33 | 0.069 | ||
| S100A2 | S100 calcium binding protein A2 | 0.069 | Human | |
| NRP2 | neuropilin 2 | 0.068 | ||
| ALAS1 | aminolevulinate, delta-, synthase 1 | 0.068 | ||
| AXL | AXL receptor tyrosine kinase | 0.068 | ||
| HOXC10 | homeobox C10 | 0.068 | ||
| RHOU | ras homolog gene family, member U | 0.068 | ||
| HOXC6 | homeobox C6 | 0.067 | Human | |
| TLN1 | talin 1 | 0.066 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.064 | ||
| INADL | InaD-like (Drosophila) | 0.064 | ||
| ACTN4 | actinin, alpha 4 | 0.064 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.064 | ||
| HOXB9 | homeobox B9 | 0.064 | ||
| EFNA5 | ephrin-A5 | 0.063 | ||
| LAT | linker for activation of T cells | 0.063 | ||
| SH3D19 | SH3 domain containing 19 | 0.062 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.062 | ||
| CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.061 | ||
| SPP1 | secreted phosphoprotein 1 | 0.061 | ||
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.060 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.057 | ||
| PKP3 | plakophilin 3 | 0.056 | ||
| EPHB3 | EPH receptor B3 | 0.056 | Human | |
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.055 | ||
| ACTN1 | actinin, alpha 1 | 0.055 | ||
| MSN | moesin | 0.054 | ||
| ANXA1 | annexin A1 | 0.054 | ||
| VEGFC | vascular endothelial growth factor C | 0.054 | Human Mouse | |
| RBPMS | RNA binding protein with multiple splicing | 0.053 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.052 | ||
| CCND2 | cyclin D2 | 0.052 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.052 | Human | |
| EZR | ezrin | 0.051 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.050 | ||
| TPM2 | tropomyosin 2 (beta) | 0.050 | ||
| SMAD6 | SMAD family member 6 | 0.050 | ||
| FURIN | furin (paired basic amino acid cleaving enzyme) | 0.049 | ||
| FOSL1 | FOS-like antigen 1 | 0.047 | ||
| AHNAK | AHNAK nucleoprotein | 0.047 | ||
| KRT15 | keratin 15 | 0.047 | ||
| PARVA | parvin, alpha | 0.047 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.046 | ||
| HOXA2 | homeobox A2 | 0.046 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.046 | ||
| EPHB2 | EPH receptor B2 | 0.046 | Human | |
| CAPG | capping protein (actin filament), gelsolin-like | 0.046 | ||
| SNTB2 | syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) | 0.046 | ||
| GHR | growth hormone receptor | 0.045 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.045 | ||
| CCND3 | cyclin D3 | 0.045 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.045 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.045 | ||
| CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.043 | ||
| CNKSR1 | connector enhancer of kinase suppressor of Ras 1 | 0.043 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.043 | ||
| HOXA6 | homeobox A6 | 0.043 | Human | |
| PLCG1 | phospholipase C, gamma 1 | 0.043 | ||
| DTNB | dystrobrevin, beta | 0.042 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.042 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.042 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.041 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.041 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.041 | ||
| SYDE1 | synapse defective 1, Rho GTPase, homolog 1 (C. elegans) | 0.041 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.040 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.040 | Human | |
| DLC1 | deleted in liver cancer 1 | 0.040 | ||
| VCL | vinculin | 0.040 | ||
| HOXC4 | homeobox C4 | 0.040 | Human | |
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.039 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.039 | ||
| RHOA | ras homolog gene family, member A | 0.039 | ||
| ANTXR2 | anthrax toxin receptor 2 | 0.038 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.038 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.038 | ||
| JAG1 | jagged 1 | 0.038 | ||
| ILK | integrin-linked kinase | 0.038 | Rat | |
| EPHA3 | EPH receptor A3 | 0.038 | ||
| DIAPH1 | diaphanous homolog 1 (Drosophila) | 0.037 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.037 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.037 | ||
| HOMER3 | homer homolog 3 (Drosophila) | 0.036 | ||
| GYPC | glycophorin C (Gerbich blood group) | 0.036 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.036 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.036 | ||
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.036 | ||
| DPYSL4 | dihydropyrimidinase-like 4 | 0.035 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.035 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.035 | Rat | |
| FLT4 | fms-related tyrosine kinase 4 | 0.034 | Human | |
| TGFA | transforming growth factor, alpha | 0.034 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.034 | ||
| BMP1 | bone morphogenetic protein 1 | 0.034 | ||
| LAMB3 | laminin, beta 3 | 0.034 | ||
| PALLD | palladin, cytoskeletal associated protein | 0.033 | ||
| CLIC1 | chloride intracellular channel 1 | 0.033 | ||
| SDC2 | syndecan 2 | 0.033 | ||
| LAMA5 | laminin, alpha 5 | 0.033 | ||
| RHOC | ras homolog gene family, member C | 0.033 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.032 | ||
| LIN7A | lin-7 homolog A (C. elegans) | 0.032 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.031 | ||
| ITGA6 | integrin, alpha 6 | 0.031 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.031 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.030 | ||
| PRRX1 | paired related homeobox 1 | 0.030 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.030 | ||
| UTRN | utrophin | 0.030 | ||
| PVR | poliovirus receptor | 0.029 | ||
| HOXA3 | homeobox A3 | 0.029 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.029 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.029 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.029 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.028 | Zebrafish | |
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.028 | ||
| SH3PXD2A | SH3 and PX domains 2A | 0.028 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.028 | ||
| DDX4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 0.028 | ||
| TSG101 | tumor susceptibility gene 101 | 0.028 | ||
| SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.028 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.027 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.027 | ||
| SKIL | SKI-like oncogene | 0.027 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.027 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.026 | ||
| ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0.026 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.026 | ||
| HOXA11 | homeobox A11 | 0.026 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.026 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.026 | ||
| NPHP1 | nephronophthisis 1 (juvenile) | 0.026 | ||
| ERBB2IP | erbb2 interacting protein | 0.026 | ||
| OSMR | oncostatin M receptor | 0.026 | ||
| LDLR | low density lipoprotein receptor | 0.026 | ||
| MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0.026 | ||
| SPHK1 | sphingosine kinase 1 | 0.026 | ||
| HNF1B | HNF1 homeobox B | 0.026 | ||
| ARL4C | ADP-ribosylation factor-like 4C | 0.026 | ||
| HOXB2 | homeobox B2 | 0.025 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.025 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.025 | ||
| EFNB1 | ephrin-B1 | 0.025 | Human | |
| PARVB | parvin, beta | 0.025 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.025 | ||
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.025 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.025 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.025 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.025 | ||
| S100A10 | S100 calcium binding protein A10 | 0.024 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.024 | ||
| HIPK3 | homeodomain interacting protein kinase 3 | 0.024 | ||
| OR2AG1 | olfactory receptor, family 2, subfamily AG, member 1 | 0.024 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.024 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.024 | ||
| AMOT | angiomotin | 0.024 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.024 | ||
| S100P | S100 calcium binding protein P | 0.024 | Human | |
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.024 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.024 | ||
| EPHB6 | EPH receptor B6 | 0.023 | Human | |
| ZNF71 | zinc finger protein 71 | 0.023 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.023 | ||
| BCR | breakpoint cluster region | 0.023 | ||
| FRZB | frizzled-related protein | 0.022 | ||
| ADAM9 | ADAM metallopeptidase domain 9 | 0.022 | ||
| CSTA | cystatin A (stefin A) | 0.022 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.022 | ||
| FILIP1L | filamin A interacting protein 1-like | 0.022 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.022 | ||
| SNTB1 | syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) | 0.022 | ||
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.022 | ||
| HOXC8 | homeobox C8 | 0.022 | Human | |
| CAST | calpastatin | 0.022 | ||
| HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C | 0.022 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.021 | ||
| EPB41 | erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) | 0.021 | ||
| HPS6 | Hermansky-Pudlak syndrome 6 | 0.021 | ||
| RHOD | ras homolog gene family, member D | 0.021 | Mouse | |
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.021 | ||
| STC2 | stanniocalcin 2 | 0.021 | ||
| SPINT1 | serine peptidase inhibitor, Kunitz type 1 | 0.021 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.021 | Human | |
| ROBO2 | roundabout, axon guidance receptor, homolog 2 (Drosophila) | 0.021 | ||
| ACVR1 | activin A receptor, type I | 0.021 | Human | |
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.021 | ||
| SDC1 | syndecan 1 | 0.020 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.020 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.020 | ||
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.020 | ||
| SSTR3 | somatostatin receptor 3 | 0.020 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.020 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.020 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.020 | ||
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.020 | ||
| SCMH1 | sex comb on midleg homolog 1 (Drosophila) | 0.020 | ||
| BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.020 | ||
| LNX1 | ligand of numb-protein X 1 | 0.020 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.020 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.020 | ||
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.020 | ||
| HOXC9 | homeobox C9 | 0.020 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.020 | ||
| QKI | quaking homolog, KH domain RNA binding (mouse) | 0.020 | ||
| KIAA1217 | KIAA1217 | 0.020 | ||
| FOXA2 | forkhead box A2 | 0.020 | ||
| STC1 | stanniocalcin 1 | 0.020 | ||
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.019 | ||
| PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.019 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.019 | ||
| ECM1 | extracellular matrix protein 1 | 0.019 | ||
| TMSB10 | thymosin beta 10 | 0.019 | ||
| HOXC11 | homeobox C11 | 0.019 | ||
| DMD | dystrophin | 0.019 | Human Mouse | |
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.019 | ||
| MUC1 | mucin 1, cell surface associated | 0.019 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.019 | Human | |
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.019 | ||
| AEBP1 | AE binding protein 1 | 0.019 | ||
| FERMT2 | fermitin family member 2 | 0.019 | ||
| CHST3 | carbohydrate (chondroitin 6) sulfotransferase 3 | 0.019 | ||
| COL8A1 | collagen, type VIII, alpha 1 | 0.019 | ||
| NAV3 | neuron navigator 3 | 0.019 | ||
| GIPC1 | GIPC PDZ domain containing family, member 1 | 0.018 | ||
| HOXB4 | homeobox B4 | 0.018 | Human | |
| ITGB5 | integrin, beta 5 | 0.018 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.018 | ||
| PAWR | PRKC, apoptosis, WT1, regulator | 0.018 | ||
| NCL | nucleolin | 0.018 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.018 | ||
| LIMK1 | LIM domain kinase 1 | 0.018 | ||
| CD34 | CD34 molecule | 0.018 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.018 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.018 | ||
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.018 | ||
| CRYAB | crystallin, alpha B | 0.018 | ||
| MEF2A | myocyte enhancer factor 2A | 0.018 | ||
| HOXC5 | homeobox C5 | 0.018 | Human | |
| MMP19 | matrix metallopeptidase 19 | 0.018 | ||
| PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.018 | ||
| ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | 0.018 | ||
| NFIX | nuclear factor I/X (CCAAT-binding transcription factor) | 0.018 | ||
| MAPT | microtubule-associated protein tau | 0.017 | ||
| THBD | thrombomodulin | 0.017 | ||
| SNX9 | sorting nexin 9 | 0.017 | ||
| SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0.017 | ||
| FGB | fibrinogen beta chain | 0.017 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.017 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.017 | ||
| PLXDC1 | plexin domain containing 1 | 0.017 | ||
| STAB1 | stabilin 1 | 0.017 | ||
| LAMC2 | laminin, gamma 2 | 0.017 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.017 | ||
| DEF6 | differentially expressed in FDCP 6 homolog (mouse) | 0.017 | ||
| S100A12 | S100 calcium binding protein A12 | 0.017 | Human | |
| THY1 | Thy-1 cell surface antigen | 0.017 | ||
| EPHA4 | EPH receptor A4 | 0.017 | Human | |
| MRAS | muscle RAS oncogene homolog | 0.017 | ||
| PHLDA3 | pleckstrin homology-like domain, family A, member 3 | 0.017 | ||
| TCF4 | transcription factor 4 | 0.017 | ||
| CDK14 | cyclin-dependent kinase 14 | 0.017 | ||
| ARVCF | armadillo repeat gene deleted in velocardiofacial syndrome | 0.017 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.016 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.016 | Human | |
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.016 | ||
| FES | feline sarcoma oncogene | 0.016 | ||
| TEAD1 | TEA domain family member 1 (SV40 transcriptional enhancer factor) | 0.016 | ||
| POM121 | POM121 membrane glycoprotein | 0.016 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.016 | ||
| CTNNBIP1 | catenin, beta interacting protein 1 | 0.016 | ||
| SH3GL3 | SH3-domain GRB2-like 3 | 0.016 | ||
| CAV2 | caveolin 2 | 0.016 | ||
| CD97 | CD97 molecule | 0.016 | ||
| SOCS6 | suppressor of cytokine signaling 6 | 0.016 | ||
| FRMD5 | FERM domain containing 5 | 0.016 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.015 | Human | |
| CNTNAP2 | contactin associated protein-like 2 | 0.015 | ||
| HOXC13 | homeobox C13 | 0.015 | ||
| PITPNM1 | phosphatidylinositol transfer protein, membrane-associated 1 | 0.015 | ||
| BGN | biglycan | 0.015 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.015 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.015 | ||
| KNG1 | kininogen 1 | 0.015 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.015 | ||
| EPS8L2 | EPS8-like 2 | 0.015 | ||
| MSC | musculin | 0.015 | ||
| ITGB8 | integrin, beta 8 | 0.015 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.015 | ||
| THAP2 | THAP domain containing, apoptosis associated protein 2 | 0.015 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.015 | ||
| RSU1 | Ras suppressor protein 1 | 0.015 | ||
| C8A | complement component 8, alpha polypeptide | 0.015 | ||
| ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | 0.015 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.015 | ||
| HIC1 | hypermethylated in cancer 1 | 0.015 | ||
| LPP | LIM domain containing preferred translocation partner in lipoma | 0.015 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.015 | ||
| THBS1 | thrombospondin 1 | 0.015 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.014 | Human | |
| ANXA5 | annexin A5 | 0.014 | ||
| TEAD3 | TEA domain family member 3 | 0.014 | ||
| ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 0.014 | ||
| PCDH7 | protocadherin 7 | 0.014 | ||
| PACSIN3 | protein kinase C and casein kinase substrate in neurons 3 | 0.014 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.014 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.014 | ||
| TBX2 | T-box 2 | 0.014 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.014 | ||
| HDAC9 | histone deacetylase 9 | 0.014 | ||
| SH3BP1 | SH3-domain binding protein 1 | 0.014 | ||
| SCG5 | secretogranin V (7B2 protein) | 0.014 | ||
| PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 0.014 | ||
| DKK3 | dickkopf homolog 3 (Xenopus laevis) | 0.014 | ||
| MYCT1 | myc target 1 | 0.014 | ||
| SOX7 | SRY (sex determining region Y)-box 7 | 0.014 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.014 | ||
| SHB | Src homology 2 domain containing adaptor protein B | 0.014 | ||
| ZNF331 | zinc finger protein 331 | 0.014 | ||
| EPHB4 | EPH receptor B4 | 0.014 | Human | |
| SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.014 | ||
| PML | promyelocytic leukemia | 0.014 | ||
| PDE4DIP | phosphodiesterase 4D interacting protein | 0.014 | ||
| TBC1D1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 | 0.014 | ||
| TMEM158 | transmembrane protein 158 (gene/pseudogene) | 0.014 | ||
| CRP | C-reactive protein, pentraxin-related | 0.014 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.014 | ||
| PDPN | podoplanin | 0.014 | ||
| RNF17 | ring finger protein 17 | 0.014 | ||
| CSPG4 | chondroitin sulfate proteoglycan 4 | 0.014 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.014 | ||
| PRKCQ | protein kinase C, theta | 0.014 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.014 | ||
| IGFBP6 | insulin-like growth factor binding protein 6 | 0.014 | ||
| KIAA1033 | KIAA1033 | 0.014 | ||
| CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.014 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.014 | ||
| DGKA | diacylglycerol kinase, alpha 80kDa | 0.014 | ||
| CLDN1 | claudin 1 | 0.014 | ||
| COL7A1 | collagen, type VII, alpha 1 | 0.014 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.014 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.014 | ||
| HOXD10 | homeobox D10 | 0.014 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.014 | ||
| AMOTL2 | angiomotin like 2 | 0.014 | ||
| GRIP1 | glutamate receptor interacting protein 1 | 0.014 | ||
| HEG1 | HEG homolog 1 (zebrafish) | 0.014 | ||
| SOCS2 | suppressor of cytokine signaling 2 | 0.014 | ||
| CREBBP | CREB binding protein | 0.014 | ||
| DLGAP4 | discs, large (Drosophila) homolog-associated protein 4 | 0.014 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.014 | ||
| SLC26A10 | solute carrier family 26, member 10 | 0.014 | ||
| MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 0.014 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.014 | ||
| PLEKHA1 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 | 0.013 | Human | |
| COL6A3 | collagen, type VI, alpha 3 | 0.013 | ||
| S100A3 | S100 calcium binding protein A3 | 0.013 | Human | |
| SCAF1 | SR-related CTD-associated factor 1 | 0.013 | ||
| ZNF205 | zinc finger protein 205 | 0.013 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.013 | ||
| PKN2 | protein kinase N2 | 0.013 | ||
| PRSS23 | protease, serine, 23 | 0.013 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.013 | ||
| HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 0.013 | ||
| ZNF426 | zinc finger protein 426 | 0.013 | ||
| CALCRL | calcitonin receptor-like | 0.013 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.013 | ||
| UNC5B | unc-5 homolog B (C. elegans) | 0.013 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.013 | ||
| PLD2 | phospholipase D2 | 0.013 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.013 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.013 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.013 | ||
| ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.013 | ||
| CTSB | cathepsin B | 0.013 | ||
| CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | 0.013 | ||
| PHOX2B | paired-like homeobox 2b | 0.013 | ||
| EMCN | endomucin | 0.013 | ||
| CD93 | CD93 molecule | 0.013 | ||
| VASP | vasodilator-stimulated phosphoprotein | 0.013 | ||
| SLIT3 | slit homolog 3 (Drosophila) | 0.013 | ||
| TPBG | trophoblast glycoprotein | 0.013 | ||
| CRABP2 | cellular retinoic acid binding protein 2 | 0.013 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.013 | ||
| ORM1 | orosomucoid 1 | 0.013 | ||
| ADAM17 | ADAM metallopeptidase domain 17 | 0.013 | Human | |
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.013 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.013 | ||
| PODXL | podocalyxin-like | 0.013 | ||
| MECOM | MDS1 and EVI1 complex locus | 0.013 | ||
| NUMB | numb homolog (Drosophila) | 0.013 | ||
| ZFYVE26 | zinc finger, FYVE domain containing 26 | 0.013 | ||
| RHOB | ras homolog gene family, member B | 0.013 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.013 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.013 | ||
| MALL | mal, T-cell differentiation protein-like | 0.013 | ||
| PGR | progesterone receptor | 0.013 | ||
| CHRD | chordin | 0.012 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.012 | ||
| CLDN4 | claudin 4 | 0.012 | ||
| PLEKHA2 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 | 0.012 | ||
| CD63 | CD63 molecule | 0.012 | ||
| EFS | embryonal Fyn-associated substrate | 0.012 | ||
| MXRA8 | matrix-remodelling associated 8 | 0.012 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.012 | ||
| CAPN2 | calpain 2, (m/II) large subunit | 0.012 | ||
| AP2A1 | adaptor-related protein complex 2, alpha 1 subunit | 0.012 | ||
| INHBB | inhibin, beta B | 0.012 | ||
| CD9 | CD9 molecule | 0.012 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.012 | ||
| ING2 | inhibitor of growth family, member 2 | 0.012 | ||
| EMP3 | epithelial membrane protein 3 | 0.012 | Human | |
| UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.012 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.012 | ||
| PF4 | platelet factor 4 | 0.012 | ||
| HDAC7 | histone deacetylase 7 | 0.012 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.012 | ||
| TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 0.012 | ||
| SMTN | smoothelin | 0.012 | ||
| SRI | sorcin | 0.012 | ||
| HOXB8 | homeobox B8 | 0.012 | Human | |
| EPAS1 | endothelial PAS domain protein 1 | 0.012 | ||
| HOXD8 | homeobox D8 | 0.012 | Human | |
| STRN3 | striatin, calmodulin binding protein 3 | 0.012 | ||
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.012 | ||
| NOTCH1 | notch 1 | 0.012 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.012 | ||
| SMAD5 | SMAD family member 5 | 0.012 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.012 | ||
| APLNR | apelin receptor | 0.012 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.012 | ||
| PTHLH | parathyroid hormone-like hormone | 0.012 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.012 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.012 | ||
| RNF144B | ring finger protein 144B | 0.012 | ||
| EDN1 | endothelin 1 | 0.012 | ||
| MDFI | MyoD family inhibitor | 0.012 | ||
| NUAK1 | NUAK family, SNF1-like kinase, 1 | 0.012 | ||
| FGD1 | FYVE, RhoGEF and PH domain containing 1 | 0.012 | ||
| CRABP1 | cellular retinoic acid binding protein 1 | 0.012 | ||
| FMNL1 | formin-like 1 | 0.012 | ||
| LPAR4 | lysophosphatidic acid receptor 4 | 0.012 | ||
| CARD10 | caspase recruitment domain family, member 10 | 0.012 | ||
| ADAM10 | ADAM metallopeptidase domain 10 | 0.012 | ||
| ANK2 | ankyrin 2, neuronal | 0.012 | ||
| DPPA4 | developmental pluripotency associated 4 | 0.012 | ||
| CHGB | chromogranin B (secretogranin 1) | 0.012 | ||
| ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) | 0.012 | ||
| RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.012 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.012 | ||
| CAPN10 | calpain 10 | 0.012 | ||
| PTPRG | protein tyrosine phosphatase, receptor type, G | 0.012 | ||
| SMAD1 | SMAD family member 1 | 0.012 | ||
| PERP | PERP, TP53 apoptosis effector | 0.012 | ||
| FGFR4 | fibroblast growth factor receptor 4 | 0.012 | ||
| PRKCA | protein kinase C, alpha | 0.012 | ||
| CDCP1 | CUB domain containing protein 1 | 0.011 | ||
| TUBA1A | tubulin, alpha 1a | 0.011 | ||
| PTPRK | protein tyrosine phosphatase, receptor type, K | 0.011 | ||
| FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | 0.011 | Human | |
| NOTCH2NL | notch 2 N-terminal like | 0.011 | ||
| PDE10A | phosphodiesterase 10A | 0.011 | ||
| CRIP1 | cysteine-rich protein 1 (intestinal) | 0.011 | ||
| PLK2 | polo-like kinase 2 | 0.011 | ||
| SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 0.011 | ||
| EGR1 | early growth response 1 | 0.011 | ||
| ASAP2 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 | 0.011 | ||
| FBXW11 | F-box and WD repeat domain containing 11 | 0.011 | ||
| SMO | smoothened homolog (Drosophila) | 0.011 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.011 | ||
| B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | 0.011 | ||
| SDC4 | syndecan 4 | 0.011 | Rat | |
| DAPK3 | death-associated protein kinase 3 | 0.011 | ||
| NOTCH4 | notch 4 | 0.011 | ||
| KIF13B | kinesin family member 13B | 0.011 | ||
| KRT19 | keratin 19 | 0.011 | ||
| RASGEF1C | RasGEF domain family, member 1C | 0.011 | ||
| PIM1 | pim-1 oncogene | 0.011 | ||
| SFRP2 | secreted frizzled-related protein 2 | 0.011 | ||
| CXCR7 | chemokine (C-X-C motif) receptor 7 | 0.011 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.011 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.011 | Human | |
| LIFR | leukemia inhibitory factor receptor alpha | 0.011 | ||
| PRKACB | protein kinase, cAMP-dependent, catalytic, beta | 0.011 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.011 | ||
| CNTNAP4 | contactin associated protein-like 4 | 0.011 | ||
| EXT1 | exostosin 1 | 0.011 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.011 | ||
| BNC1 | basonuclin 1 | 0.011 | ||
| SCN2A | sodium channel, voltage-gated, type II, alpha subunit | 0.011 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.011 | ||
| RASSF7 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 | 0.011 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.011 | ||
| ZBTB16 | zinc finger and BTB domain containing 16 | 0.011 | ||
| EBF2 | early B-cell factor 2 | 0.011 | ||
| PTK7 | PTK7 protein tyrosine kinase 7 | 0.011 | ||
| CMIP | c-Maf-inducing protein | 0.011 | ||
| BAMBI | BMP and activin membrane-bound inhibitor homolog (Xenopus laevis) | 0.011 | ||
| HOXD3 | homeobox D3 | 0.011 | ||
| SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | 0.011 | ||
| LEPREL1 | leprecan-like 1 | 0.011 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.011 | ||
| DNAJB5 | DnaJ (Hsp40) homolog, subfamily B, member 5 | 0.011 | ||
| CD248 | CD248 molecule, endosialin | 0.011 | ||
| CNN2 | calponin 2 | 0.011 | ||
| LLGL2 | lethal giant larvae homolog 2 (Drosophila) | 0.011 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.011 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.011 | ||
| MBNL2 | muscleblind-like 2 (Drosophila) | 0.011 | ||
| MYOF | myoferlin | 0.011 | ||
| NID1 | nidogen 1 | 0.011 | ||
| GREM1 | gremlin 1 | 0.011 | Mouse | |
| VWF | von Willebrand factor | 0.011 | ||
| ZEB1 | zinc finger E-box binding homeobox 1 | 0.011 | ||
| PIP4K2B | phosphatidylinositol-5-phosphate 4-kinase, type II, beta | 0.011 | ||
| COL10A1 | collagen, type X, alpha 1 | 0.011 | ||
| PTPRD | protein tyrosine phosphatase, receptor type, D | 0.011 | ||
| TP53I11 | tumor protein p53 inducible protein 11 | 0.011 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.011 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.011 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.011 | ||
| CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.011 | ||
| DACT1 | dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) | 0.011 | ||
| CCDC134 | coiled-coil domain containing 134 | 0.011 | ||
| AKAP6 | A kinase (PRKA) anchor protein 6 | 0.011 | ||
| NGFRAP1 | nerve growth factor receptor (TNFRSF16) associated protein 1 | 0.011 | ||
| BCL6B | B-cell CLL/lymphoma 6, member B | 0.011 | ||
| FOXD1 | forkhead box D1 | 0.011 | ||
| MAP2 | microtubule-associated protein 2 | 0.011 | ||
| ETV4 | ets variant 4 | 0.011 | ||
| PCDH1 | protocadherin 1 | 0.011 | ||
| PPP1R13L | protein phosphatase 1, regulatory (inhibitor) subunit 13 like | 0.011 | ||
| RYK | RYK receptor-like tyrosine kinase | 0.011 | ||
| PCDH17 | protocadherin 17 | 0.011 | ||
| DKK4 | dickkopf homolog 4 (Xenopus laevis) | 0.011 | ||
| PRSS8 | protease, serine, 8 | 0.011 | ||
| ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 0.011 | ||
| TAGLN2 | transgelin 2 | 0.011 | ||
| GNB5 | guanine nucleotide binding protein (G protein), beta 5 | 0.011 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.011 | ||
| OR1F1 | olfactory receptor, family 1, subfamily F, member 1 | 0.011 | ||
| ANGPT4 | angiopoietin 4 | 0.011 | ||
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.011 | ||
| BCL2L2 | BCL2-like 2 | 0.011 | ||
| GJB5 | gap junction protein, beta 5, 31.1kDa | 0.011 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.011 | ||
| PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 0.010 | ||
| TMEM47 | transmembrane protein 47 | 0.010 | ||
| BMP7 | bone morphogenetic protein 7 | 0.010 | ||
| NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.010 | ||
| MFAP5 | microfibrillar associated protein 5 | 0.010 | ||
| GAS7 | growth arrest-specific 7 | 0.010 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.010 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.010 | ||
| ZNF420 | zinc finger protein 420 | 0.010 | ||
| PITPNM2 | phosphatidylinositol transfer protein, membrane-associated 2 | 0.010 | ||
| RPH3A | rabphilin 3A homolog (mouse) | 0.010 | ||
| FAM65A | family with sequence similarity 65, member A | 0.010 | ||
| GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 0.010 | ||
| ST13 | suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) | 0.010 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.010 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.010 | ||
| DOCK8 | dedicator of cytokinesis 8 | 0.010 | ||
| MYO1E | myosin IE | 0.010 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.010 | ||
| MPZL2 | myelin protein zero-like 2 | 0.010 | ||
| HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.010 | ||
| ZFP106 | zinc finger protein 106 homolog (mouse) | 0.010 | ||
| COL11A1 | collagen, type XI, alpha 1 | 0.010 | ||
| EDIL3 | EGF-like repeats and discoidin I-like domains 3 | 0.010 | ||
| COL5A3 | collagen, type V, alpha 3 | 0.010 | ||
| SOX4 | SRY (sex determining region Y)-box 4 | 0.010 | ||
| SRPK3 | SRSF protein kinase 3 | 0.010 | ||
| PSG9 | pregnancy specific beta-1-glycoprotein 9 | 0.010 | ||
| PLVAP | plasmalemma vesicle associated protein | 0.010 | ||
| CAMSAP1L1 | calmodulin regulated spectrin-associated protein 1-like 1 | 0.010 | ||
| FLNA | filamin A, alpha | 0.010 | ||
| PLSCR3 | phospholipid scramblase 3 | 0.010 | ||
| EFNA3 | ephrin-A3 | 0.010 | Human | |
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.010 | ||
| MYOZ2 | myozenin 2 | 0.010 | ||
| CCNA1 | cyclin A1 | 0.010 | ||
| KRT81 | keratin 81 | 0.010 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.010 | ||
| PLLP | plasmolipin | 0.010 | ||
| TSPO | translocator protein (18kDa) | 0.010 | ||
| FOXF2 | forkhead box F2 | 0.010 | ||
| KRT6B | keratin 6B | 0.010 | ||
| TACSTD2 | tumor-associated calcium signal transducer 2 | 0.010 | ||
| NRCAM | neuronal cell adhesion molecule | 0.010 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.010 | ||
| SESN2 | sestrin 2 | 0.010 | ||
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.010 | ||
| DUSP7 | dual specificity phosphatase 7 | 0.010 | ||
| FZD5 | frizzled homolog 5 (Drosophila) | 0.010 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.010 | ||
| RGS12 | regulator of G-protein signaling 12 | 0.010 | ||
| EMP1 | epithelial membrane protein 1 | 0.010 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.010 | ||
| WNT10A | wingless-type MMTV integration site family, member 10A | 0.010 | ||
| F2RL1 | coagulation factor II (thrombin) receptor-like 1 | 0.010 | ||
| F2RL2 | coagulation factor II (thrombin) receptor-like 2 | 0.010 | ||
| EHD1 | EH-domain containing 1 | 0.010 | ||
| SOX13 | SRY (sex determining region Y)-box 13 | 0.010 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.010 | ||
| AQP3 | aquaporin 3 (Gill blood group) | 0.010 | ||
| PROCR | protein C receptor, endothelial | 0.010 | ||
| AMT | aminomethyltransferase | 0.010 | ||
| NPAS2 | neuronal PAS domain protein 2 | 0.010 | ||
| HIST1H1T | histone cluster 1, H1t | 0.010 | ||
| MYBPH | myosin binding protein H | 0.010 | ||
| VAT1 | vesicle amine transport protein 1 homolog (T. californica) | 0.010 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.010 | ||
| EBF1 | early B-cell factor 1 | 0.010 |